Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer

Indian Council of Medical Research. National Cancer Registry Programme: Five year consolidated report of hospital based cancer registries 1984–1998. New Delhi, India: ICMR; 2002. Brenner, 2004, Treatment of localized esophageal cancer, Semin Oncol, 31, 554, 10.1053/j.seminoncol.2004.04.015 1986 1988 Li, 2003, Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma, World J Gastroenterol, 9, 2395, 10.3748/wjg.v9.i11.2395 Katada, 1997, Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus, Arch Surg, 132, 728, 10.1001/archsurg.1997.01430310042007 Coppola, 1999, Significance of Fas and retinoblastoma protein expression during the progression of Barrett's metaplasia to adenocarcinoma, Ann Surg Oncol, 6, 298, 10.1007/s10434-999-0298-7 Monteiro, 2004, Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure, Cancer Detect Prev, 28, 237, 10.1016/j.cdp.2004.04.005 Nandakumar, 1996, Importance of anatomical subsite in correlating risk factors in cancer of the oesophagus—report of a case–control study, Br J Cancer, 73, 1306, 10.1038/bjc.1996.249 Christein, 2002, Prognostic factors associated with resectable carcinoma of the esophagus, Am Surg, 68, 258, 10.1177/000313480206800308 Peters, 1999, Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease, Exp Hematol, 27, 868, 10.1016/S0301-472X(99)00033-8 Singhal, 2005, Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review, Clin Cancer Res, 11, 3974, 10.1158/1078-0432.CCR-04-2661 Chu, 2005, Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2, Cancer Res, 65, 5301, 10.1158/0008-5472.CAN-04-3270 Charo, 2005, Bcl-2 overexpression enhances tumor-specific T-cell survival, Cancer Res, 65, 2001, 10.1158/0008-5472.CAN-04-2006 Komaki, 1998, The polymorphic 43Thr bcl-2 protein confers relative resistance to autoimmunity: an analytical evaluation, Hum Genet, 103, 435, 10.1007/s004390050847 Betticher, 1995, Alternate splicing produces a novel cyclin D1 transcript, Oncogene, 11, 1005 Hinds, 1994, Function of a human cyclin gene as an oncogene, Proc Natl Acad Sci U S A, 91, 709, 10.1073/pnas.91.2.709 Izzo, 2003, Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer, J Natl Cancer Inst, 95, 198, 10.1093/jnci/95.3.198 Yu, 2003, Lack of association between CCND1 G870A polymorphism and risk of esophageal squamous cell carcinoma, Cancer Epidemiol Biomarkers Prev, 12, 176 Zhang, 2003, Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population, Int J Cancer, 105, 281, 10.1002/ijc.11067 French, 1996, Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnover, Behring Inst Mitt, 97, 156 Sun, 2004, Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma, J Natl Cancer Inst, 96, 1030, 10.1093/jnci/djh187 Jain, 2006, GSTT1, GSTM1 and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India, Cancer Lett, 242, 60, 10.1016/j.canlet.2005.10.034 Pandey, 2006, Genetic polymorphisms in GSM1, GSTT1, GSTP1, GSTM3 and susceptibility to gallbladder cancer in North India, Biomarkers, 11, 250, 10.1080/13547500600648697 Wu, 2004, Association of FAS (TNFRSF6)-670 gene polymorphism with villous atrophy in coeliac disease, World J Gastroenterol, 10, 717, 10.3748/wjg.v10.i5.717 Zhang, 2004, Use of pyrosequencing to detect clinically relevant polymorphisms of genes in basal cell carcinoma, Clin Chim Acta, 342, 137, 10.1016/j.cccn.2003.12.010 Yoon, 2003, Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study, Radiology, 227, 764, 10.1148/radiol.2281020423 Hockenbery, 1990, Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature, 348, 334, 10.1038/348334a0 Metzger, 2004, Molecular biology of esophageal cancer, Onkologie, 27, 200, 10.1159/000076913 Ohbu, 1997, Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis, Cancer, 79, 1287, 10.1002/(SICI)1097-0142(19970401)79:7<1287::AID-CNCR3>3.0.CO;2-E Kanemitsu, 2002, A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus, J Rheumatol, 29, 1183 Gratas, 1998, Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer, Cancer Res, 58, 2057 Shibakita, 1999, Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer, Clin Cancer Res, 5, 2464 Casson, 2005, Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma, Cancer, 104, 730, 10.1002/cncr.21229 Izzo, 2005, Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis, Semin Oncol, 32, S11, 10.1053/j.seminoncol.2005.04.023 Katiyar, 2005, p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India, Cancer Lett, 218, 69, 10.1016/j.canlet.2004.09.003 Catarino, 2005, Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism, Cancer Genet Cytogenet, 160, 49, 10.1016/j.cancergencyto.2004.11.017 Ueda, 2005, Fas gene promoter -670 polymorphism (A/G) is associated with cervical carcinogenesis, Gynecol Oncol, 98, 129, 10.1016/j.ygyno.2005.04.001